VI

VIVUS INC

  • CIK: 0000881524
  • EIN: 94-3136179
  • Business address: 900 E. HAMILTON AVENUE, SUITE 550, CAMPBELL, California, 95008

Information

  • Mailing address
    900 E. HAMILTON AVENUE, SUITE 550, CAMPBELL, Delaware, 95008
  • Phone
    6509345200
  • State location
    California
  • State of incorporation
    Delaware
  • Fiscal year end
    December 31
  • SIC
    2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS
  • Filings
    N/A

About VIVUS INC

VIVUS INC (CIK: 0000881524) is an American company incorporated in the state of California. Head office is located at 900 E. HAMILTON AVENUE, SUITE 550, CAMPBELL, California, 95008. Work in the industry 2834 - (CF Office: Office of Life Sciences) PHARMACEUTICAL PREPARATIONS. VIVUS INC is a public company and trade via Over-The-Counter (OTC).

Ownership

Owner Filings Transaction Date Type of Owner
KANGAS EDWARD A 0001211047 Oct-26-2018 director
Ferrell Karen E. 0001756909 Oct-26-2018 director
Suh Kenneth 0001748982 Aug-03-2018 officer: President
Oehrlein M. Scott 0001738174 Apr-30-2018 officer: Chief Operations Officer
Amos John P. 0001738557 Apr-30-2018 director, officer: Chief Executive Officer
KING THOMAS BRAXTON 0001279309 May-24-2017 director
Oki Mark K 0001491847 Oct-19-2015 officer: Chief Financial Officer & CAO
Mohamed Johann Noor 0001654742 Oct-01-2015 officer: Interim CFO & Interim CAO
Roberts Eric W 0001576244 Sep-15-2015 director
Sris Mayu 0001588777 Sep-15-2015 director
Shaw Allan 0001626850 Sep-15-2015 director
Varghese Santosh T 0001640688 Apr-28-2015 officer: VP, Medical & Reg Affairs
NORTH TIDE CAPITAL, LLC 0001557543 Dec-30-2014 10 percent owner
Laughlin Conan 0001594068 Dec-30-2014 10 percent owner
North Tide Capital Master, LP 0001594882 Dec-30-2014 10 percent owner
Sanford Svai S 0001591411 Nov-05-2013 officer: Interim CFO
Fischer Seth H.Z. 0001573553 Sep-03-2013 director, officer: Chief Executive Officer
Zook Anthony P. 0001582393 Jul-22-2013 officer: Chief Executive Officer
ASTRUE MICHAEL J 0001236367 Jul-19-2013 director
Colin Samuel F 0001458243 Jul-19-2013 director
JOHANNES JACOB PIETER KASTELEIN 0001582710 Jul-19-2013 director
FIRST MANHATTAN CO 0000728083 May-23-2013 10 percent owner, other: SEE REMARKS
BIRO JON C 0001221219 May-23-2013 10 percent owner, other: SEE REMARKS
ROSENMAN HERM 0001230057 May-23-2013 10 percent owner, other: SEE REMARKS
KEATING MELVIN L 0001263463 May-23-2013 10 percent owner, other: SEE REMARKS
First BioMed Management Associates LLC 0001458280 May-23-2013 10 percent owner, other: SEE REMARKS
Norton David Y 0001529193 May-23-2013 10 percent owner, other: SEE REMARKS
Bass Rolf E. 0001578709 May-23-2013 10 percent owner, other: SEE REMARKS
DENNER ALEXANDER J 0001361754 May-22-2013 10 percent owner, other: See Footnotes 1,2
Sarissa Capital Domestic Fund LP 0001575277 May-22-2013 10 percent owner, other: See Footnotes 1,2
Sarissa Capital Management LP 0001577524 May-22-2013 10 percent owner, other: See Footnotes 1,2
Sarissa Capital Offshore Master Fund LP 0001577530 May-22-2013 10 percent owner, other: See Footnotes 1,2
Plutzky Jorge MD 0001576525 May-10-2013 director
CARROLL J MARTIN 0001279901 May-09-2013 director
WILSON ROBERT N 0001189022 Apr-26-2013 director
MARIO ERNEST 0001180469 Apr-18-2012 director
MILLER MICHAEL /NY/ 0001164242 Jan-27-2012 officer: Chief Commercial Officer
MILLER MICHAEL PATRICK 0001236514 Apr-26-2010 officer: SVP, Chief Commercial Officer
MORRIS TIMOTHY E 0001191286 Jan-22-2010 officer: VP, Finance & CFO
Perry Lee 0001387455 Jan-22-2010 officer: VP & Chief Accounting Officer
Slebir John L 0001475990 Oct-30-2009 officer: General Counsel & Asst. Sec.
MARSH GUY P 0001251618 Aug-24-2009 officer: VP, Operations & General Mgr
Day Wesley 0001341526 Jan-23-2009 officer: VP, Clinical Research
TAM PETER Y 0001251107 Dec-01-2008 officer: SVP, Product & Corporate Dev.
CASAMENTO CHARLES J 0001117167 Apr-17-2008 director
PLACE VIRGIL A 0001251622 Aug-28-2007 officer: Chief Scientific Officer
Changjin Wang 0001379645 Nov-01-2006 officer: VP, Business Development
LOGAN MARK B 0001220354 Jun-14-2006 director
STRACHAN GRAHAM 0001251104 Jun-14-2006 director
SHORTLIFFE LINDA M DAIRIKI 0001254533 Jun-14-2006 director
WILSON LELAND F 0001008170 Apr-18-2005 director, officer: President & CEO
ROSATI MARIO M 0001197808 Apr-18-2005 director
Forrest Lori 0001307960 Nov-03-2004 other: Corporate Controller
DIETRICH JOHN W 0001251106 Feb-23-2004 officer: Vice President, R & D
ZOLTOWSKI CAROL 0001251105 Jan-27-2004 officer: Vice President, Regulatory
GESUNDHEIT NEIL 0001251619 Jan-27-2004 officer: VP, Chief Medical Officer
NIDA TERRY 0001251623 Jan-27-2004 officer: VP, Worldwide Marketing/
WALLISER RICHARD W 0001251620 Dec-31-2003 officer: CFO
NICKEL JAMES R 0001271350 Nov-24-2003 officer: Vice President, Clinical
STRAUSS LARRY J 0001263049 Sep-21-2003 officer: Vice President, Finance & CFO

Stock Chart

Coming soon!

Jobs

Coming soon!

Recent SEC Filings

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by VIVUS INC

Filings Format Description Filed/Effective File/Film Number
15-12B Document

Notice of termination of registration of a class of securities under Section 12(b)

Acc-no: 0001104659-21-002522 (34 Act) Size: KB		 Jan-08-2021

001-33389

21518097
SC 13G/A Document

Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions

Acc-no: 0001535610-21-000026 (34 Act) Size: KB		 Jan-05-2021

005-48777

21504994
EFFECT Document Acc-no: 9999999995-20-003692 (33 Act) Size: KB Dec-30-2020

333-227353

201427406
EFFECT Document Acc-no: 9999999995-20-003691 (33 Act) Size: KB Dec-30-2020

333-105985

201427411
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140298 (33 Act) Size: KB		 Dec-30-2020

033-80362

201423911
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140296 (33 Act) Size: KB		 Dec-30-2020

033-75698

201423908
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140295 (33 Act) Size: KB		 Dec-30-2020

333-06486

201423907
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140293 (33 Act) Size: KB		 Dec-30-2020

333-29939

201423904
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140291 (33 Act) Size: KB		 Dec-30-2020

333-57374

201423901
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140290 (33 Act) Size: KB		 Dec-30-2020

333-73394

201423900
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140289 (33 Act) Size: KB		 Dec-30-2020

333-104287

201423899
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140287 (33 Act) Size: KB		 Dec-30-2020

333-107006

201423898
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140286 (33 Act) Size: KB		 Dec-30-2020

333-142354

201423896
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140285 (33 Act) Size: KB		 Dec-30-2020

333-150647

201423894
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140283 (33 Act) Size: KB		 Dec-30-2020

333-157787

201423889
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140282 (33 Act) Size: KB		 Dec-30-2020

333-164921

201423881
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140281 (33 Act) Size: KB		 Dec-30-2020

333-168106

201423880
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140279 (33 Act) Size: KB		 Dec-30-2020

333-175926

201423879
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140278 (33 Act) Size: KB		 Dec-30-2020

333-199881

201423878
S-8 POS Document

Post-effective amendment to a S-8 registration statement

Acc-no: 0001104659-20-140277 (33 Act) Size: KB		 Dec-30-2020

333-215089

201423874

Recent 20 filings. View all VIVUS INC filings

Reviews

Overall rating 5.0

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

Frequently Asked Questions

Tags:

  • VIVUS INC overview
  • VIVUS INC job
  • VIVUS INC stock
  • VIVUS INC ownership
  • VIVUS INC CEO
  • VIVUS INC documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.

Orther Companies

Metsera, Inc.
Update: Nov 21, 2024
Curanex Pharmaceuticals Inc
Update: Oct 17, 2024
Apimeds Pharmaceuticals US, Inc.
Update: Sep 26, 2024
Upstream Bio, Inc.
Update: Sep 19, 2024
Bicara Therapeutics Inc.
Update: Aug 23, 2024
Stramsen Biotech, Inc.
Update: May 21, 2024

Latest News

SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate Conflicts of Interest
SEC Adopts Rules to Improve Clearing Agency Governance and Mitigate...
SEC Press Releases  Nov 17, 2023 3631 Views
Charter Communications to Pay $25 Million Penalty for Unauthorized Stock Buybacks
Charter Communications to Pay $25 Million Penalty for Unauthorized...
SEC Press Releases  Nov 15, 2023 4887 Views
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Announces Enforcement Results for Fiscal Year 2023
SEC Press Releases  Nov 15, 2023 2228 Views
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries for Falsifying Documents While Raising $70 Million From Investors
SEC Charges Former Co-CEOs of Tech Start-Up Bitwise Industries...
SEC Press Releases  Nov 10, 2023 1417 Views
SEC Charges Royal Bank of Canada with Internal Accounting Controls Violations
SEC Charges Royal Bank of Canada with Internal Accounting Controls...
SEC Press Releases  Nov 03, 2023 1667 Views
SEC Charges President/CCO of Prophecy Asset Management Advisory Firm with Multi-Year Fraud
SEC Charges President/CCO of Prophecy Asset Management Advisory...
SEC Press Releases  Nov 03, 2023 3625 Views
SEC Adopts Rules for the Registration and Regulation of Security-Based Swap Execution Facilities
SEC Adopts Rules for the Registration and Regulation of Security-Based...
SEC Press Releases  Nov 02, 2023 1155 Views
SEC Charges Crypto Company SafeMoon and its Executive Team for Fraud and Unregistered Offering of Crypto Securities
SEC Charges Crypto Company SafeMoon and its Executive Team for...
SEC Press Releases  Nov 01, 2023 1763 Views
SEC Charges Four Long Island Men with Perpetrating $2 Million “Free-Riding” Scheme
SEC Charges Four Long Island Men with Perpetrating $2 Million...
SEC Press Releases  Nov 01, 2023 4513 Views

© 2022 CompaniesBIO.Com. All rights reserved. Operated by